돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 217160생성일: 2026년 10월 25일

5-Iodosalicylic acid → N-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-butyl]-2-hydroxy-5-iodo-benzamide

https://huagongshe.com/reaction/217160

반응식

참여 물질

역할이름HCID투입량
반응물5-Iodosalicylic acidHCID 8388—
반응물N-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-2-hydroxy-5-methylbenzamideHCID 16738306—
생성물N-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-butyl]-2-hydroxy-5-iodo-benzamideHCID 16734984—

반응 단계

Compound 2e was prepared form 2-hydroxy-5-iodo-benzoic acid and 1b as described above for 2a. The yield of 2c was 27.0%. The 1H-NMR spectrum (300 MHz, CDCl3) of the purified product was: 1.69-1.81 (m, 4H), 2.54-2.65 (m, 2H), 2.75-2.83 (m, 2H), 3.44-3.48 (m, 2H), 3.58 (s, 2H), 3.82 (s, 3H), 3.85 (s, 3H), 6.50 (s, 1H), 6.58 (s, 1H), 6.70-6.74 (d, 1H), 7.54-7.55 (d, 1H), 7.65-7.67 (d, 1H), 8.20 (s, 1H). Anal. (C22H27IN2O4.0.75H2O) C, H, N.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08193360B2
출처 데이터셋uspto-grants-2012_06
ORD IDord-277c7c700e17445e964ed65450d34e5c
출처 메모uspto-grants-2012_06